Leuthold Group LLC Has $6.52 Million Stock Holdings in Tenet Healthcare Corporation $THC

Leuthold Group LLC lifted its position in Tenet Healthcare Corporation (NYSE:THC) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,784 shares of the company’s stock after acquiring an additional 2,912 shares during the period. Leuthold Group LLC’s holdings in Tenet Healthcare were worth $6,515,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Triumph Capital Management acquired a new stake in Tenet Healthcare during the 3rd quarter worth approximately $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare during the 4th quarter worth approximately $26,000. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare during the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. Finally, Westside Investment Management Inc. raised its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares during the period. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

NYSE THC opened at $196.39 on Friday. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The firm’s 50 day moving average is $199.44 and its 200-day moving average is $203.75. The company has a market capitalization of $16.92 billion, a PE ratio of 10.21, a price-to-earnings-growth ratio of 1.31 and a beta of 1.30.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period last year, the business earned $4.36 earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post 17.64 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Thomas W. Arnst sold 24,000 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the transaction, the executive vice president directly owned 8,012 shares of the company’s stock, valued at $1,875,128.48. This represents a 74.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 46,517 shares of company stock valued at $10,943,111. 0.81% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have commented on THC. Royal Bank Of Canada dropped their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. Guggenheim lowered their price objective on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Robert W. Baird lowered their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $244.16.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.